Disease Activity

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
Gerd R Burmester, Vibeke Strand, Andrea Rubbert-Roth, Howard Amital, Tatiana Raskina, Antonio Gómez-Centeno, Claudia Pena-Rossi, Leon Gervitz, Karthinathan Thangavelu, Gregory St John, Susan Boklage, Mark C Genovese

RMD Open Oct 2019, 5 (2) e001017; DOI: 10.1136/rmdopen-2019-001017
Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
Denis Mongin, Kim Lauper, Carl Turesson, Merete Lund Hetland, Eirik Klami Kristianslund, Tore K Kvien, Maria Jose Santos, Karel Pavelka, Florenzo Iannone, Axel Finckh, Delphine Sophie Courvoisier

RMD Open Oct 2019, 5 (2) e000994; DOI: 10.1136/rmdopen-2019-000994
Impact of the combined presence of erosions and ACPA on rheumatoid arthritis disease activity over time: results from the METEOR registry
Sytske Anne Bergstra, Maura C Couto, Nimmisha Govind, Arvind Chopra, Karen Salomon Escoto, Elizabeth Murphy, Tom WJ Huizinga, Cornelia F Allaart

RMD Open Jul 2019, 5 (2) e000969; DOI: 10.1136/rmdopen-2019-000969
Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study
Joachim Sieper, Robert Landewé, Marina Magrey, Jaclyn K Anderson, Sheng Zhong, Xin Wang, Apinya Lertratanakul

RMD Open Jun 2019, 5 (1) e000917; DOI: 10.1136/rmdopen-2019-000917
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial
Iain B McInnes, Gianfranco Ferraccioli, Maria-Antonietta D'Agostino, Manuela Le Bars, Subhashis Banerjee, Harris A Ahmad, Yedid Elbez, Philip J Mease

RMD Open May 2019, 5 (1) e000934; DOI: 10.1136/rmdopen-2019-000934
Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry
Philip J Mease, Carol J Etzel, William J Huster, Talia M Muram, April W Armstrong, Jeffrey R Lisse, Sabrina Rebello, Rhiannon Dodge, Mwangi James Murage, Jeffrey D Greenberg, William N Malatestinic

RMD Open May 2019, 5 (1) e000867; DOI: 10.1136/rmdopen-2018-000867
Time in remission and low disease activity state (LDAS) are associated with a better quality of life in patients with systemic lupus erythematosus: results from LUMINA (LXXIX), a multiethnic, multicentre US cohort
Manuel Francisco Ugarte-Gil, Guillermo J Pons-Estel, Luis M Vila, Gerald McGwin, Graciela S Alarcón

RMD Open May 2019, 5 (1) e000955; DOI: 10.1136/rmdopen-2019-000955
Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis
Maria Backström, Pirjo Tynjälä, Kristiina Aalto, Minna-Maija Grönlund, Heikki Ylijoki, Anne Putto-Laurila, Johanna Kärki, Paula Keskitalo, Sirja Sard, Heini Pohjankoski, Maiju Hietanen, Silke Witter, Helena Lehto, Eliisa Löyttyniemi, Paula Vähäsalo

RMD Open Apr 2019, 5 (1) e000888; DOI: 10.1136/rmdopen-2018-000888
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
Frank Buttgereit, Vibeke Strand, Eun Bong Lee, Abraham Simon-Campos, Dorothy McCabe, Astrid Genet, Brinda Tammara, Ricardo Rojo, Judith Hey-Hadavi

RMD Open Apr 2019, 5 (1) e000889; DOI: 10.1136/rmdopen-2018-000889
Neural networks for automatic scoring of arthritis disease activity on ultrasound images
Jakob Kristian Holm Andersen, Jannik Skyttegaard Pedersen, Martin Sundahl Laursen, Kathrine Holtz, Jakob Grauslund, Thiusius Rajeeth Savarimuthu, Søren Andreas Just

RMD Open Mar 2019, 5 (1) e000891; DOI: 10.1136/rmdopen-2018-000891

Main menu

Disease Activity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Disease Activity

Pages